The topical spironolaktone - renaissance in adult onset acne

• In: Individualised Medicine Posters
• At: Lisbon (Portugal) (2010)
• Type: Poster
• Poster code: IM-P-002
• By: SER, Filip (City Departement for Skin and veneral Diseases, Belgrade, Yugoslavia)
• Co-author(s): Djurovic, Dragan (Medicines and Medical Devices Agency of Serbia, BELGRADE, Serbia)
  Gajdas, Mirjana (Pharmacy Belgrade, BELGRADE, Serbia)
  Pavlovic, Tina (Pharmacy Belgrade, BELGRADE, Serbia)
  Sarenac, Svetlana (Pharmacy Belgrade, BELGRADE, Serbia)
  Ivanic, Vanja (Pharmacy Diafarm, BELGRADE, Serbia)
  Plazinic, Olivera (Pharmacy Diafarm, BELGRADE, Serbia)
  Bakalovic, Irena (Pharmacy Diafarm, BELGRADE, Serbia)
  Celeketic, Zorana (Pharmacy Belgrade, BELGRADE, Serbia)
  Stojsic, Radmila (Pharmacy Belgrade, BELGRADE, Serbia)
  Petronijevic, Dragoslav (Pharmacy Belgrade, BELGRADE, Serbia)
  
• Abstract:

  The acne of adult onset is in a majority of cases associated with the need for anti-androgen medication. Even in the absence of clearly demonstrated androgen excess, antiandrogens used topically are of a great value. Spironolactone was originally developed in the early 1970's as a competitive antagonist of aldosterone for the treatment of..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login